NCT00007163View on ClinicalTrials.gov

Monoclonal Antibody Treatment of Crohn's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2000

Study Completion Date

November 30, 2002

Conditions
Crohn's Disease
Interventions
DRUG

J695

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00007163 - Monoclonal Antibody Treatment of Crohn's Disease | Biotech Hunter | Biotech Hunter